Search Within

Martee L Hensley

  1. "Early Drug Development Service"
Formats
  1. Journal Article (13)
  2. Meeting Abstract (10)
  3. Book Section (1)
Groups
  1. Department of Medicine (24)
  2. Early Drug Development Service (24)
  3. GDMT, Medicine (24)
  4. Gynecologic Medicine Service (24)
  5. Gynecology Disease Management Team (24)
  6. Solid Tumor Oncology Division (24)

More Groups

People
  1. David Hyman (18)
  2. Carol Aghajanian (14)
  3. Rachel Grisham (14)
  4. Roisin O'Cearbhaill (13)
  5. Jason Konner (12)
  6. William Tew (12)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (1)
  4. 2022 (2)
  5. 2021 (1)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Clinical Cancer Research (3)
  3. Gynecologic Oncology (2)
  4. American Journal of Surgical Pathology (1)
  5. Cancer (1)
  6. Current Opinion in Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. American Association for Cancer Research (4)
  3. Lippincott Williams & Wilkins (3)
  4. Elsevier Inc. (2)
  5. Nature Publishing Group (1)
  6. Springer (1)

More Publishers

Results (24)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade
    Journal Article

    Boland, J. L.; Zhou, Q.; Martin, M.; Callahan, M. K.; Konner, J.; O'Cearbhaill, R. E.; Friedman, C. F.; Tew, W.; Makker, V.; Grisham, R. N.; more...
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • The clinical utility of prospective molecular characterization in advanced cervical and vulvovaginal cancer
    Meeting Abstract

    Friedman, C. F.; Donoghue, M.; Vivek, M.; Aghajanian, C.; Abu-Rustum, N.; Cadoo, K. A.; Grisham, R. N.; Hensley, M. L.; Konner, J. A.; Kyi, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Clinical utility of prospective molecular characterization in advanced endometrial cancer
    Journal Article

    Soumerai, T. E.; Donoghue, M. T. A.; Bandlamudi, C.; Srinivasan, P.; Chang, M. T.; Zamarin, D.; Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Tew, W. P.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • A randomized trial of prophylactic extended carboplatin infusion to reduce hypersensitivity reactions in recurrent ovarian cancer
    Journal Article

    LaVigne, K.; Hyman, D. M.; Zhou, Q. C.; Iasonos, A.; Tew, W. P.; Aghajanian, C.; Makker, V.; Hensley, M. L.; Konner, J.; Grisham, R. N.; more...
    International Journal of Gynecological Cancer (2018)

    Fulltext@MSK | Save
  • A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Somatic mutations in homologous recombination pathway genes in ovarian cancer
    Meeting Abstract

    Aghajanian, C.; DeLair, D.; Grisham, R. N.; Hensley, M. L.; Konner, J. A.; Makker, V.; O'Cearbhaill, R. E.; Sabbatini, P.; Soumerai, T.; Charen, A. S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase 2 study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group study 0231D
    Journal Article

    Hyman, D. M.; Sill, M. W.; Lankes, H. A.; Piekarz, R.; Shahin, M. S.; Ridgway, M. R.; Backes, F.; Tenney, M. E.; Mathews, C. A.; Hoffman, J. S.; more...
    Gynecologic Oncology (2017)

    Fulltext@MSK | Save
  • Identifying actionable mutations in uterine leiomyosarcoma
    Meeting Abstract

    Soumerai, T.; Hyman, D. M.; Murali, R.; Zehir, A.; O'Cearbhaill, R. E.; Arcila, M. E.; Aghajanian, C.; Soslow, R. A.; Solit, D. B.; Hensley, M. L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Carboplatin hypersensitivity reactions (HSR) in carboplatin retreatment for recurrent ovarian cancer
    Meeting Abstract

    O'Cearbhaill, R. E.; Hyman, D. M.; Tew, W. P.; Iasonos, A.; Cangemi, N. A.; Aghajanian, C.; Bell-Mcguinn, K. M.; Makker, V.; Hensley, M. L.; Konner, J. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase II study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-0231D)
    Meeting Abstract

    Hyman, D. M.; Sill, M.; Cho, J. K.; Lankes, H. A.; Piekarz, R.; Hensley, M. L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save